Share markets in India ended the day on weak note tracking mixed global cues as markets remained jittery after fresh nuclear test by North Korea and claims that it tested a hydrogen bomb over the weekend. At the closing bell, the BSE Sensex closed lower by 190 points. While, the NSE Nifty finished lower by 62 points. Meanwhile, both the S&P BSE Midcap Index and the S&P BSE Small Cap Index ended down by 0.7%.

All BSE sectoral indices ended the day in negative zone. Among them, realty index fell 1.4%, followed by information technology sector 1% and banking sector 0.8%.

Overseas, Asian equity markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.37%, while the Nikkei 225 led the Hang Seng lower. They fell 0.93% and 0.76% respectively. European markets are lower today with shares in Germany off the most. The DAX is down 0.50% while France’s CAC 40 is off 0.49% and London’s FTSE 100 is lower by 0.18%.

The rupee was trading at Rs 64.05 against the US$ in the afternoon session. Oil prices were trading at US$ 47.34 at the time of writing.

Coal India share price rallied over 3.2% after it reported provisional production of 37.63 million tonnes (MT) in August 2017, as against a target of 36.96 MT. The company’s total off-take for the month of August stood at 43.75 MT, as against a target of 43.09 MT.

Pharma stocks closed the day on a mixed note with Piramal Enterprises and J.B. Chemicals leading the losses. Lupin share price finished on an optimistic note after the company announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market.

The company has launched the tablets in strengths of 5 mg, 20 mg and 40 mg after having received an approval from the United States Food and Drug Administration (FDA) earlier.